$Moderna (MRNA.US)$ now, the issue is that whether it would ...
$Moderna (MRNA.US)$ now, the issue is that whether it would be pausible to soar to the price 400 next year or not? it's too late to sell all the shares for me.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Alaness : This would be an uncertainty and placing Faith and trust in the company in their next direction after covid. I doubt being a big playing field they will die out so easily. But it will take time to reach that price again that’s for sure
102314945 : india has their own vaccine approve, china, rusia the same. even in us they are losing to pfizer and most of ppl is already vacinated. do you think it will go up next year?
Virushunter : If you look at their pipeline, they are targeting cancers, other viral infections and rare orphan diseases so I think they will be ok over long term. Covid has already established them as a major mRNA player and brand.
Alaness : Yeah this is what I find funny. I use another example which is ATER. One of their Clinical trial failed the phase 2. Only phase 2 btw. And their share plunged 75%. U can go take a look. It’s like everyone presumes that the company only have one product and one research only. It’s damn funny how ppl think sometimes. Let me put it simply. If covid vaccine is selling the best atm def I’ll conc most of my resources to that but doesn’t mean I’ll neglect my other projects. As the report says it has other projects going on too but they are in early stages. It’s doesn’t mean moderna only have one product and sells one product. IN any case comparing other pharm stocks seeing how it only drops 10-15% I’m alr in awe tbh. Other Pharm stocks I see the moment they fail one trial or even FDA says delay approval, the shares plunge like as though this company is absolutely worthless
Alaness : Sorry it’s not ATER. It’s AVIR!!! Too many similar names hahahah